Harmine hydrochloride

N/A

Report date: 2023/01/03 17:55:54
NME

Base Information

Drug NameHarmine hydrochloride
Drug Alias NameTelepathine hydrochlorideHarmineTelepathine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitorsDYRK kinase inhibitorsClk dual-specificity kinase inhibitors +[5] 
TargetsDual-specificity tyrosine-phosphorylation regulated kinase 1ADYRK kinaseDual specificity protein kinase CLK +[5] 
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Diabetes And Digestive And Kidney Diseases
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center FreiburgIcahn School Of Medicine At Mount SinaiNational Institute Of Diabetes And Digestive And Kidney Diseases
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A